Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 07, 2007. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the US Retirement Savings Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share allocation notifications rather than financial performance metrics.
Material Changes
The filing details an increase in the notional allocation of Ordinary Share ADRs within the US Retirement Savings Plan following a re-valuation of the cash element. The transactions occurred on August 02, 2007, at a price of $51.86 per share. Specific allocations included:
- Dr R G Greig: 81 shares
- Dr J P Garnier: 75 shares
- Mr D M Stout: 39 shares
- Dr D Pulman: 16 shares
- Dr M M Slaoui: 2 shares
- Mrs C Bruck Slaoui: 1 share
- Mr W C Louv: 6 shares
- Mr C Viehbacher: 6 shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a compliance notification under Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Investor Verification Points
- Verify the total number of shares allocated to directors and connected persons on August 02, 2007.
- Confirm the share price of $51.86 used for the notional allocation.
- Review the specific Disclosure Rules (3.1.4R) cited to ensure compliance with UK listing requirements.